Author/Authors :
Tayebi khosroshahi, Hamid Kidney Research Center - Tabriz University of Medical Sciences, Tabriz, Iran , Zarrintan, Armin Medical Radiation Sciences Research group - Tabriz University of Medical Sciences, Tabriz, Iran , Manaflouyan, Hesam Medical Radiation Sciences Research group - Tabriz University of Medical Sciences, Tabriz, Iran , Rahmanpour, Dara Medical Radiation Sciences Research group - Tabriz University of Medical Sciences, Tabriz, Iran , Farashi, Ebrahim Student Research Committee - Tabriz University of Medical Sciences, Tabriz, Iran , Mousavi-Aghdas, Ali Medical Radiation Sciences Research group - Tabriz University of Medical Sciences, Tabriz, Iran , Mirza-Aghazadeh-Attari, Mohammad Medical Radiation Sciences Research group - Tabriz University of Medical Sciences, Tabriz, Iran , Tarzamni, Mohammad Kazem Medical Radiation Sciences Research group - Tabriz University of Medical Sciences, Tabriz, Iran
Abstract :
Background: Coronavirus disease 2019 (COVID-19) has infected millions and caused tens of thousands of casualties. Epidemiologic studies show that specific individuals with pre-existing conditions are prone to severe disease caused by the virus. Thus, it is necessary
to determine clinical signs and symptoms and disease progression course in various pre-existing conditions, namely end-stage
renal disease (ESRD) patients undergoing hemodialysis.
Methods: The present retrospective study was conducted on 17 ESRD patients undergoing chronic hemodialysis. Clinical signs and
symptoms were extracted, and laboratory test results and imaging findings were retrieved using the health information systems of
the institute where the study was performed.
Results: Of 17 patients in the study, six patients were females, and 11 were males. The mean age of the patients was 62.2915.6 years
(22 - 82). The mostcommonpre-existing conditions were hypertension and diabetes. The mostcommonimaging signs were groundglass
opacities. The most common pattern of involvement was peripheral, bilateral, and multifocal involvement, and interestingly,
uncommon imaging signs such as crazy-paving, peribronchovascular involvement, and reticulonodular pattern of involvement.
The most common laboratory findings were lymphopenia, lymphocytosis, increased erythrocyte sedimentation rate, and positive
C reactive protein.
Conclusions: ESRD patients undergoing COVID-19 seem to have higher mortalities than the general public and show more significant lung involvement on chest CT imaging. Furthermore, uncommon imaging signs are more common in this group of patients.
Keywords :
COVID-19 , Hemodialysis , ESRD , Infection , SARS-CoV-2